SUZHOU, China — High-value dealmakers are moving early to lock in dedicated meeting spaces for 1:1 business development discussions at BIOCHINA 2027, returning to Suzhou, China on March 10–12, 2027.

As global cross-border dealmaking reaches unprecedented momentum, international buy-in for BIOCHINA 2027 is already locked in—25 overseas institutions across 15 countries have already committed to 8 exhibition booths and 27 Partnering Passes.

Industry Leaders Securing Private Meeting Suites

Leading biopharmaceutical enterprises are reserving dedicated suites within the BIOCHINA 2027 Meeting Room Program to host high-stakes, face-to-face partner discussions:

• Chia Tai Tianqing (CTTQ): Fresh off its landmark $123 million out-licensing deal with India’s Cipla for TQB2102 (a novel HER2 biparatopic bispecific ADC), CTTQ’s executive team has officially joined BIOCHINA 2027 for 1:1 Partnering to explore next-generation strategic partnerships.
• Livzon Pharmaceutical: Confirmed for the BIOCHINA 2027 Meeting Room Program, hosting targeted 1:1 partner meetings with global biotech delegates and investors.

Secure Your Partnering Seat Today

Early bird pricing is currently open. Don't miss the opportunity to seat your leadership team across the table from top-tier Asian and global biopharma decision-makers.

• Event Dates: March 10–12, 2027
• Location: Suzhou, China
• Official Portal Registration: https://u.morebio.cn/yQvMJntQ